Pakissan.com; The Transgenic Plant

Transgenic or genetically modified (GM) plants are contributing to many areas of industry, including increased crop production and enhanced food qualify in agriculture; production of monoclonal antibodies, therapeutic proteins, and edible vaccines for the pharmaceutical industry; and environmentally friendly outputs such as biodegradable plastics. As the practice of inserting desirable gene sequences continues to find new markets, the companies involved continue to change drastically. Cross-industry mergers and a proliferation of new entrants vying to cash in on the latest technologies have left even insiders struggling to make sense of the playing field.

D&MD's Market Analysis Report 'The Transgenic Plant Market' sheds considerable light on more than 60 companies with a stake in transgene technology. The Report not only helps make sense of the recent industry shuffling, it highlights the significant outputs from GM plants, where ongoing research is headed, and what commercially viable products are on the horizon. Finally recent controversies and regulations stemming from the introduction of GM products around the world are discussed.

The benefits of transgenic plants come with their share of controversies and regulations. Today's major issues include concerns over unwanted pollen drift, intellectual property rights and patent litigations, and EU requirements for products free of gene markets. Additionally, some foreign markets are demanding labelling of GM products, increasing the need for detection and testing methods.

Request a free copy of the table of contents and executive summary of is Report by sending an email or website

Product cost options
Print & CD versions USD8,000.00
CD version USD4,950.00
Print version USD4,950.00
Domestic shipping USD 20.00
International shipping USD 50.00

Source: Business Recorder

Pakissan.com;